Replies to post #6772 on Vericel Corp. (VCEL)

[lasers]

Not much I can add to what I have already posted.

The Asians especially Japanese and Chinese are taking increasing Partnership positions with USA growth Pharmas.

$VCEL has already signed contracts with ICT for sales of all of $VCEL pipeline into the China, South Korean, and Singapore

What would be your objections with ICT as Partner for Ixcell?

Dr. Lei Xiao, Chairman of ICT commented "MACI, Epicel and Carticel are FDA approved products and have successfully treated thousands of patients in United States. Ixmyelocel-T has been evaluated in a phase II study in the U.S., and the encouraging data suggest that it may be a treatment option for millions of heart failure patients. This collaboration enables ICT to bring world-class cell therapy products to China and other Asian countries which will benefit the patients in multiple therapeutic indications. By combining with our advanced CAR-T portfolio, ICT further strengthens its leadership position in Cell Therapies in Asia."

http://investors.vcel.com/releasedetail.cfm?ReleaseID=1025740